Metabolites › GXBYLUZTDNFHPE-HBTOKZPTSA-N

mithramycin DK

(2S,3S)-6-{[2,6-dideoxy-3-O-(2,6-dideoxy-β-D-arabino-hexopyranosyl)-β-D-arabino-hexopyranosyl]oxy}-8,9-dihydroxy-3-[(1S,3S)-3-hydroxy-1-methoxy-2,4-dioxopentyl]-7-methyl-1-oxo-1,2,3,4-tetrahydroanthracen-2-yl 2,6-dideoxy-3-C-methyl-β-D-ribo-hexopyranosyl-(1→3)-2,6-dideoxy-β-D-lyxo-hexopyranosyl-(1→3)-2,6-dideoxy-β-D-arabino-hexopyranoside

GXBYLUZTDNFHPE-HBTOKZPTSA-N CHEBI:81906 0 Reactome links 1 studies
1 Observed studies
2 Observed diff profiles
0 Reactome pathways

Metabolite details

Identifier
GXBYLUZTDNFHPE-HBTOKZPTSA-N
InChI Key
GXBYLUZTDNFHPE-HBTOKZPTSA-N
IUPAC name
(2S,3S)-6-{[2,6-dideoxy-3-O-(2,6-dideoxy-β-D-arabino-hexopyranosyl)-β-D-arabino-hexopyranosyl]oxy}-8,9-dihydroxy-3-[(1S,3S)-3-hydroxy-1-methoxy-2,4-dioxopentyl]-7-methyl-1-oxo-1,2,3,4-tetrahydroanthracen-2-yl 2,6-dideoxy-3-C-methyl-β-D-ribo-hexopyranosyl-(1→3)-2,6-dideoxy-β-D-lyxo-hexopyranosyl-(1→3)-2,6-dideoxy-β-D-arabino-hexopyranoside
Preferred name
mithramycin DK
INN name
—
Synonym
4'-keto-mithramycin
ChEBI
CHEBI:81906

Reactome pathways

  • No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles